RecruitingNCT05441969

In Vivo Cortical Excitability Modulation in Major Depressive Disorder


Sponsor

Fundacao Champalimaud

Enrollment

90 participants

Start Date

May 19, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The pathophysiology of Major Depression Disorder (MDD) is unclear, with several theories for its neurobiological mechanisms. One possible explanation is the presence of altered neuroplasticity, which can be studied by Transcranial Magnetic Stimulation (TMS). Using TMS to study these mechanisms is performed by applying electromagnetic stimuli to the motor cortex, to obtain measures of temporary cortical excitability modulation. It is known that depressed patients with higher cortical modulation are more responsive to a TMS treatment course. However, it is unknown if there are differences in cortical modulation between depressed patients and healthy subjects. Our goal is to answer this question and contribute towards clarification of the neuroplasticity mechanisms underlying MDD. Accordingly, the investigators will access cortical excitability modulation measures in both depressed patients and healthy volunteers and compare their results. The investigators will also re-assess these measures after 6 weeks of antidepressant treatment. Finally, the investigators will study the association between cortical excitability measures and cognitive processes using an innovative cognitive task.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how the brain's activity and responsiveness (called cortical excitability) differs in people with major depression compared to people without depression, using non-invasive brain stimulation and brain imaging techniques. **You may be eligible if...** - You have been diagnosed with a major depressive episode or major depressive disorder (clinical group) - OR you are a healthy adult with no psychiatric history (control group) **You may NOT be eligible if...** - You have a moderate to severe suicide risk - You have a history of bipolar disorder or psychotic disorder - You have an alcohol or substance abuse problem - You have a developmental disorder or dementia - You have epilepsy, a brain implant, or a cardiac implant - You are currently pregnant or breastfeeding - You take medications known to cause seizures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention/expousure

No interventions/expousure since this is an observational study.


Locations(1)

Champalimaud Foundation

Lisbon, Portugal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05441969


Related Trials